Yaroslav Bondarenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yaroslav Bondarenko has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Oksana I. Kauk
Kharkiv National Medical University, Kharkiv, Ukraine
9 shared publications - Denys Kulyk
Kharkiv National Medical University
7 shared publications - Nataliia Olehivna Shushliapina
Kharkiv National Medical University
5 shared publications - Kateryna Zelenska
Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
3 shared publications - Lidiya Cherkashyna
Department of General Practice–Family Medicine, Kharkiv National Medical University, Kharkiv
3 shared publications - Maryna Biriukova
Kharkiv National Medical University
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (3)
Analysis of computed tomography indicators of morphometry of the olfactory region and functional disorders in patients with nasal obstruction and dysosmia
Background. CT morphometry of the olfactory cleft (OC) reflects structural pre-requisites for olfactory dysfunction; however, its relationship with olfactory function may depend on etiology: a conductive mechanism predominates in mechanical obstruction, whereas a neurosensory mechanism may occur after SARS-CoV-2 infection. Purpose – to assess rhinomanometric, olfactometric, and CT-morphometric para-meters of the olfactory cleft in patients with olfactory dysfunction of mechanical and post-viral (COVID-19) origin and to compare the pattern of concordance of these parameters between the two etiological phenotypes. Materials and Methods. A total of 196 patients (37.4 ± 3.1 years) were examined: group 1 (n = 53) – mechanical nasal obstruction for 3–5 years; group 2 (n = 48) – up to 6 months; group 3 (n = 44) – up to 1 month; group 4 (n = 51) – post-viral rhino-sinusitis within 3 months. Rhinomanometry, Sniffin’ Sticks olfactometry, and CT using a Vatech PaX-i3D system were performed. ANOVA (η2) and the χ2 test with Cramer’s V were applied. Results. Aerodynamic resistance was 3.1 ± 0.4, 2.2 ± 0.5, 3.6 ± 0.4, and 1.3 ± 0.5 kPa·s/L, respectively (F(3,192) = 243.3; p < 0.001; η2 = 0.792). OC area was 86.5 ± 0.4, 111.1 ± 0.5, 78.8 ± 0.5, and 164.4 ± 0.8 mm2, respectively (all p < 0.001). In groups 1–3, structural and functional parameters changed concordantly. In group 4, despite the largest OC area and lowest resistance, T was 3.0 ± 1.8 points and I was 6.9 ± 2.5 points; anosmia by T occurred in 27.5% and hyposmia in 72.5%. Keros type distribution differed significantly between groups (χ2(6) = 28.09; p < 0.001; V = 0.268), with type III predominating in group 4 (50.9%). Conclusions. In mechanical nasal obstruction, morphometric and aerodynamic changes are consistent with the severity of olfactory dysfunction. After COVID-19, this relationship is absent, supporting a predominant neurosensory mechanism.
- 30 September 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (3)
Open AccessAnalysis of computed tomography indicators of morphometry of the olfactory region and functional disorders in patients with nasal obstruction and dysosmia
Background. CT morphometry of the olfactory cleft (OC) reflects structural pre-requisites for olfactory dysfunction; however, its relationship with olfactory function may depend on etiology: a conductive mechanism predominates in mechanical obstruction, whereas a neurosensory mechanism may occur after SARS-CoV-2 infection. Purpose – to assess rhinomanometric, olfactometric, and CT-morphometric para-meters of the olfactory cleft in patients with olfactory dysfunction of mechanical and post-viral (COVID-19) origin and to compare the pattern of concordance of these parameters between the two etiological phenotypes. Materials and Methods. A total of 196 patients (37.4 ± 3.1 years) were examined: group 1 (n = 53) – mechanical nasal obstruction for 3–5 years; group 2 (n = 48) – up to 6 months; group 3 (n = 44) – up to 1 month; group 4 (n = 51) – post-viral rhino-sinusitis within 3 months. Rhinomanometry, Sniffin’ Sticks olfactometry, and CT using a Vatech PaX-i3D system were performed. ANOVA (η2) and the χ2 test with Cramer’s V were applied. Results. Aerodynamic resistance was 3.1 ± 0.4, 2.2 ± 0.5, 3.6 ± 0.4, and 1.3 ± 0.5 kPa·s/L, respectively (F(3,192) = 243.3; p < 0.001; η2 = 0.792). OC area was 86.5 ± 0.4, 111.1 ± 0.5, 78.8 ± 0.5, and 164.4 ± 0.8 mm2, respectively (all p < 0.001). In groups 1–3, structural and functional parameters changed concordantly. In group 4, despite the largest OC area and lowest resistance, T was 3.0 ± 1.8 points and I was 6.9 ± 2.5 points; anosmia by T occurred in 27.5% and hyposmia in 72.5%. Keros type distribution differed significantly between groups (χ2(6) = 28.09; p < 0.001; V = 0.268), with type III predominating in group 4 (50.9%). Conclusions. In mechanical nasal obstruction, morphometric and aerodynamic changes are consistent with the severity of olfactory dysfunction. After COVID-19, this relationship is absent, supporting a predominant neurosensory mechanism.
- Open Access
- 30 September 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (3) , 28-42
A unified mechanism of cross-modal neuroplasticity: hub-based architecture, neurochemical and epigenetic regulation in sensory compensation and synesthesia
Background: Synesthesia and sensory compensation have emerged as pivotal topics in contemporary neuroscience, elucidating the remarkable adaptability of the human brain. Both phenomena demonstrate the capacity for cross-modal integration and functional reassignment of neural networks, challenging the traditional modular view of sensory processing. Although synesthesia was long regarded as a rare anomaly and sensory compensation as a secondary adaptation to sensory loss, current evidence indicates that they represent convergent manifestations of the same universal principle: the brain’s intrinsic ability to reorganize itself through neuroplasticity. Consequently, these processes illuminate not only the dynamics of perception but also broader mechanisms of cognition, creativity, and memory enhancement. Objective: This study investigated the convergent neurobiological mechanisms underlying synesthesia and sensory compensation, focusing specifically on the role of plasticity universal convergence nodes (supernodes) —including the superior colliculus, intraparietal sulcus, superior temporal sulcus, and prefrontal projections—as coordinators of sensory remapping and cross-modal integration. It was hypothesized that these structures act as dynamic hubs capable of rerouting sensory flows under conditions of deprivation or enrichment, thereby enabling both compensatory and associative forms of neuroplasticity. Methods: A systematic literature review was performed across PubMed, Scopus, Web of Science, and Google Scholar, encompassing studies published between 2000 and 2026. The search strategy employed Boolean logic and combined English and Ukrainian keywords related to “sensory compensation”, “synesthesia”, “neuroplasticity”, “multisensory integration”, and specific hub structures. Inclusion criteria encompassed experimental and clinical studies with neuroimaging (fMRI, MEG, PET, DTI), electrophysiological recordings, or molecular analyses in human participants and animal models. Review articles and meta-analyses providing integrative perspectives on multisensory plasticity were also included, while purely descriptive or metaphorical accounts were excluded. Results: Evidence across modalities demonstrates that sensory reorganization is governed by a hub-based architecture rather than diffuse activation. Primary cortices, such as V1 and A1, exhibit functional reassignment when typical input is absent, while associative hubs coordinate the redistribution and integration of multisensory information. The superior colliculus enables rapid topographic integration of cross-modal signals; the intraparietal sulcus performs coordinate transformations and oscillatory gating; the superior temporal sulcus resolves temporal correspondences in audiovisual integration; and prefrontal projections provide top-down modulation and precision weighting. These structural roles are reinforced by molecular mechanisms: neurotrophin signaling (BDNF, NT-3, IGF-1) initiates plastic readiness, while epigenetic regulation (DNA methylation, histone acetylation, noncoding RNAs) ensures stabilization and long-term retention of novel sensory maps. Together, these mechanisms establish a dual-layer system of rapid reconfiguration and durable consolidation. Importantly, the same pathways that allow the blind to develop enhanced spatial hearing or the deaf to refine visuomotor communication also support the emergence of synesthetic cross-modal associations in individuals without sensory loss. Conclusions: Synesthesia and sensory compensation should be interpreted not as exceptional deviations but as complementary expressions of a universal adaptive code of neuroplasticity. By activating supernodes, the brain dynamically reconfigures its sensory architecture in response to environmental demands, whether by necessity (compensation) or by enrichment (synesthesia). This framework has profound theoretical and practical implications. It advances our understanding of the brain as a dynamic network rather than a fixed modular system and provides translational insights into clinical neurorehabilitation, multisensory pedagogical strategies, and emerging fields of cognitive enhancement. Harnessing these mechanisms may enable new interventions—from targeted neuromodulation and neurotrophin-based therapies to educational methods that deliberately engage cross-modal correspondences—thus transforming the way we approach both deficits and potentials of the human mind.
- 30 September 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (3) , 28-42
Open AccessA unified mechanism of cross-modal neuroplasticity: hub-based architecture, neurochemical and epigenetic regulation in sensory compensation and synesthesia
Background: Synesthesia and sensory compensation have emerged as pivotal topics in contemporary neuroscience, elucidating the remarkable adaptability of the human brain. Both phenomena demonstrate the capacity for cross-modal integration and functional reassignment of neural networks, challenging the traditional modular view of sensory processing. Although synesthesia was long regarded as a rare anomaly and sensory compensation as a secondary adaptation to sensory loss, current evidence indicates that they represent convergent manifestations of the same universal principle: the brain’s intrinsic ability to reorganize itself through neuroplasticity. Consequently, these processes illuminate not only the dynamics of perception but also broader mechanisms of cognition, creativity, and memory enhancement. Objective: This study investigated the convergent neurobiological mechanisms underlying synesthesia and sensory compensation, focusing specifically on the role of plasticity universal convergence nodes (supernodes) —including the superior colliculus, intraparietal sulcus, superior temporal sulcus, and prefrontal projections—as coordinators of sensory remapping and cross-modal integration. It was hypothesized that these structures act as dynamic hubs capable of rerouting sensory flows under conditions of deprivation or enrichment, thereby enabling both compensatory and associative forms of neuroplasticity. Methods: A systematic literature review was performed across PubMed, Scopus, Web of Science, and Google Scholar, encompassing studies published between 2000 and 2026. The search strategy employed Boolean logic and combined English and Ukrainian keywords related to “sensory compensation”, “synesthesia”, “neuroplasticity”, “multisensory integration”, and specific hub structures. Inclusion criteria encompassed experimental and clinical studies with neuroimaging (fMRI, MEG, PET, DTI), electrophysiological recordings, or molecular analyses in human participants and animal models. Review articles and meta-analyses providing integrative perspectives on multisensory plasticity were also included, while purely descriptive or metaphorical accounts were excluded. Results: Evidence across modalities demonstrates that sensory reorganization is governed by a hub-based architecture rather than diffuse activation. Primary cortices, such as V1 and A1, exhibit functional reassignment when typical input is absent, while associative hubs coordinate the redistribution and integration of multisensory information. The superior colliculus enables rapid topographic integration of cross-modal signals; the intraparietal sulcus performs coordinate transformations and oscillatory gating; the superior temporal sulcus resolves temporal correspondences in audiovisual integration; and prefrontal projections provide top-down modulation and precision weighting. These structural roles are reinforced by molecular mechanisms: neurotrophin signaling (BDNF, NT-3, IGF-1) initiates plastic readiness, while epigenetic regulation (DNA methylation, histone acetylation, noncoding RNAs) ensures stabilization and long-term retention of novel sensory maps. Together, these mechanisms establish a dual-layer system of rapid reconfiguration and durable consolidation. Importantly, the same pathways that allow the blind to develop enhanced spatial hearing or the deaf to refine visuomotor communication also support the emergence of synesthetic cross-modal associations in individuals without sensory loss. Conclusions: Synesthesia and sensory compensation should be interpreted not as exceptional deviations but as complementary expressions of a universal adaptive code of neuroplasticity. By activating supernodes, the brain dynamically reconfigures its sensory architecture in response to environmental demands, whether by necessity (compensation) or by enrichment (synesthesia). This framework has profound theoretical and practical implications. It advances our understanding of the brain as a dynamic network rather than a fixed modular system and provides translational insights into clinical neurorehabilitation, multisensory pedagogical strategies, and emerging fields of cognitive enhancement. Harnessing these mechanisms may enable new interventions—from targeted neuromodulation and neurotrophin-based therapies to educational methods that deliberately engage cross-modal correspondences—thus transforming the way we approach both deficits and potentials of the human mind.
- 3 September 2026
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 2,p. 55-65
Comparative analysis of amlodipine and lercanidipine: mechanisms, limitations, and prospects of combined antihypertensive therapy
- 3 September 2026
- Published by Publishing House Helvetica (Publications) in Fitoterapia
- No. 2,p. 55-65
Comparative analysis of amlodipine and lercanidipine: mechanisms, limitations, and prospects of combined antihypertensive therapy
- 30 August 2026
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2026 (8) , 1881-1898
Why Early Preventive Check-ups Matter: Unmasking Subclinical Abnormalities in Adults Aged 18–45 via Systemic Ultrasound Phenotyping (The LUMINA Score)
Aim: To evaluate systemic multi-organ ultrasound phenotyping using VScan Air™ CL for detecting subclinical abnormalities in healthy adults aged 18–45 years and develop an integrated scoring system (LUMINA System) for early risk stratification. Material and methods: A prospective cohort study (2010–2025) enrolled 188 clinically healthy adults with normal biochemical markers, stratified into three age groups (18–26, 27–35, 36–45 years). Standardized ultrasound assessments of liver, kidneys, carotid arteries, heart, and thyroid were performed. The LUMINA System (score range: 0–29) integrated findings across organ systems. Results: Subclinical abnormalities were detected in 79.8% of participants despite normal laboratory values. Early liver steatosis occurred in 20.7%, correlating with higher BMI, triglycerides, and HOMA-IR. Increased renal echogenicity was found in 28–35% despite preserved kidney function. Carotid intima-media thickness exceeded the 75th percentile in 22.6%, with progressive vascular stiffness. Thyroid abnormalities appeared in 47.35%, suggesting autoimmune activation. Mean LUMINA scores increased from 0.44±0.31 (18–26 years) to 12.12±3.68 (27–35 years), strongly correlating with BMI (r=0.68), waist circumference (r=0.71), and HOMA-IR (r=0.54). Conclusions: Systemic ultrasound phenotyping enables early detection of multi-organ abnormalities in young adults with normal laboratory profiles. The LUMINA System provides unified preclinical risk stratification, revealing that metabolic, vascular, and endocrine remodeling coexist years before disease onset, enhancing preventive medicine through personalized intervention.
- 30 August 2026
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2026 (8) , 1881-1898
Why Early Preventive Check-ups Matter: Unmasking Subclinical Abnormalities in Adults Aged 18–45 via Systemic Ultrasound Phenotyping (The LUMINA Score)
Aim: To evaluate systemic multi-organ ultrasound phenotyping using VScan Air™ CL for detecting subclinical abnormalities in healthy adults aged 18–45 years and develop an integrated scoring system (LUMINA System) for early risk stratification. Material and methods: A prospective cohort study (2010–2025) enrolled 188 clinically healthy adults with normal biochemical markers, stratified into three age groups (18–26, 27–35, 36–45 years). Standardized ultrasound assessments of liver, kidneys, carotid arteries, heart, and thyroid were performed. The LUMINA System (score range: 0–29) integrated findings across organ systems. Results: Subclinical abnormalities were detected in 79.8% of participants despite normal laboratory values. Early liver steatosis occurred in 20.7%, correlating with higher BMI, triglycerides, and HOMA-IR. Increased renal echogenicity was found in 28–35% despite preserved kidney function. Carotid intima-media thickness exceeded the 75th percentile in 22.6%, with progressive vascular stiffness. Thyroid abnormalities appeared in 47.35%, suggesting autoimmune activation. Mean LUMINA scores increased from 0.44±0.31 (18–26 years) to 12.12±3.68 (27–35 years), strongly correlating with BMI (r=0.68), waist circumference (r=0.71), and HOMA-IR (r=0.54). Conclusions: Systemic ultrasound phenotyping enables early detection of multi-organ abnormalities in young adults with normal laboratory profiles. The LUMINA System provides unified preclinical risk stratification, revealing that metabolic, vascular, and endocrine remodeling coexist years before disease onset, enhancing preventive medicine through personalized intervention.
- Open Access
- 30 June 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (2) , 32-50
Predicting the risk of neurodegenerative diseases based on clinical microsignals
Background: Neurodegenerative diseases, in particular Parkinson’s disease, remain difficult to diagnose due to the late manifestation of classical motor symptoms, when significant neuronal degeneration has already occurred. A growing body of evidence suggests that subtle non-motor prodromal symptoms — so-called phenotypic microsignals (PMS) may precede the clinical manifestation of neurodegenerative diseases by several years. These symptoms reflect early neurochemical disturbances and disruptions of neural networks, especially in evolutionarily ancient brain structures vulnerable to α-synuclein pathology. Objective: To identify and systematize early clinical phenotypic microsignals observed during initial outpatient visits and potentially associated with neurodegenerative processes, as well as to develop a clinical risk stratification tool for the prodromal stage based on retrospective analysis and prospective observation. Materials and methods: A combined retrospective-prospective observational study conducted at Kharkiv National Medical University during the period from January 2020 to August 2025. The study involved 112 patients aged 48 to 76 years, who were divided into three groups: group 1 (n=28, prodromal/non-manifest pathology), group 2 (n=56, manifest pathology (Alzheimer’s disease (n=16), Parkinson’s disease (n=28), dementia with Lewy bodies (n=9), progressive supranuclear palsy (n=3)), group 3 (control, n=28, individuals without clinical signs of neurodegenerative pathology, matched by age and sex). A 48-point PMS scale was developed and validated, assessing 30 clinical markers across cognitive, motor, autonomic, sensory and affective domains. Patients underwent comprehensive neurological examination, cognitive testing (MMSE — Mini-Mental State Examination, MoCA — Montreal Cognitive Assessment, FAB — Frontal Assessment Battery), magnetic resonance imaging and standardized assessment of non-motor symptoms. ROC analysis was used to evaluate the predictive accuracy of the scale. Results: Patients with manifest neurodegenerative diseases had significantly higher PMS scale scores (mean value ‒ 27.8±6.3 points) compared with the prodromal group (11.4±3.8, p<0.001) and control (2.8±2.1). ROC analysis demonstrated excellent diagnostic accuracy for comparison of manifest pathology with control (area under the curve (AUC) ‒ 0.982, sensitivity ‒ 96.4%, specificity ‒ 92.9% at a threshold value ≥13 points), good accuracy for prodromal pathology compared with control (AUC ‒ 0.956, sensitivity ‒ 89.3%, specificity ‒ 89.3% at a threshold value ≥7 points) and for differentiation of manifest and prodromal pathology (AUC ‒ 0.891, sensitivity ‒ 78.6%, specificity ‒ 85.7% at a threshold value ≥21 points). Risk stratification identified three categories: low risk (0–12 points, 50% conversion). In the prodromal group, the most frequent microsignals were REM sleep behavior disorder (67.9%), hyposmia (71.4%), chronic constipation (78.6%), subjective cognitive decline (82.1%), reduced arm swing during walking (46.4%) and hypomimia (42.9%). Conclusions: The PMS scale is a clinically effective and low-cost tool for identifying individuals at risk of developing neurodegenerative diseases years before the manifestation of classical symptoms. Its use does not require specialized equipment and is feasible at the level of primary medical care through history taking, observation and basic neurological examination. The scale demonstrates high psychometric properties and provides risk stratification, enabling individualized monitoring and early intervention strategies. This approach marks a transition to proactive diagnostic models in neurology. It has significant value for screening programs among middle-aged and older individuals with subclinical neurobehavioral complaints. Early detection using PMS assessment allows timely application of neuroprotective and preventive interventions, potentially altering the course of the disease before irreversible neuronal loss.
- 30 June 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (2) , 32-50
Open AccessPredicting the risk of neurodegenerative diseases based on clinical microsignals
Background: Neurodegenerative diseases, in particular Parkinson’s disease, remain difficult to diagnose due to the late manifestation of classical motor symptoms, when significant neuronal degeneration has already occurred. A growing body of evidence suggests that subtle non-motor prodromal symptoms — so-called phenotypic microsignals (PMS) may precede the clinical manifestation of neurodegenerative diseases by several years. These symptoms reflect early neurochemical disturbances and disruptions of neural networks, especially in evolutionarily ancient brain structures vulnerable to α-synuclein pathology. Objective: To identify and systematize early clinical phenotypic microsignals observed during initial outpatient visits and potentially associated with neurodegenerative processes, as well as to develop a clinical risk stratification tool for the prodromal stage based on retrospective analysis and prospective observation. Materials and methods: A combined retrospective-prospective observational study conducted at Kharkiv National Medical University during the period from January 2020 to August 2025. The study involved 112 patients aged 48 to 76 years, who were divided into three groups: group 1 (n=28, prodromal/non-manifest pathology), group 2 (n=56, manifest pathology (Alzheimer’s disease (n=16), Parkinson’s disease (n=28), dementia with Lewy bodies (n=9), progressive supranuclear palsy (n=3)), group 3 (control, n=28, individuals without clinical signs of neurodegenerative pathology, matched by age and sex). A 48-point PMS scale was developed and validated, assessing 30 clinical markers across cognitive, motor, autonomic, sensory and affective domains. Patients underwent comprehensive neurological examination, cognitive testing (MMSE — Mini-Mental State Examination, MoCA — Montreal Cognitive Assessment, FAB — Frontal Assessment Battery), magnetic resonance imaging and standardized assessment of non-motor symptoms. ROC analysis was used to evaluate the predictive accuracy of the scale. Results: Patients with manifest neurodegenerative diseases had significantly higher PMS scale scores (mean value ‒ 27.8±6.3 points) compared with the prodromal group (11.4±3.8, p<0.001) and control (2.8±2.1). ROC analysis demonstrated excellent diagnostic accuracy for comparison of manifest pathology with control (area under the curve (AUC) ‒ 0.982, sensitivity ‒ 96.4%, specificity ‒ 92.9% at a threshold value ≥13 points), good accuracy for prodromal pathology compared with control (AUC ‒ 0.956, sensitivity ‒ 89.3%, specificity ‒ 89.3% at a threshold value ≥7 points) and for differentiation of manifest and prodromal pathology (AUC ‒ 0.891, sensitivity ‒ 78.6%, specificity ‒ 85.7% at a threshold value ≥21 points). Risk stratification identified three categories: low risk (0–12 points, 50% conversion). In the prodromal group, the most frequent microsignals were REM sleep behavior disorder (67.9%), hyposmia (71.4%), chronic constipation (78.6%), subjective cognitive decline (82.1%), reduced arm swing during walking (46.4%) and hypomimia (42.9%). Conclusions: The PMS scale is a clinically effective and low-cost tool for identifying individuals at risk of developing neurodegenerative diseases years before the manifestation of classical symptoms. Its use does not require specialized equipment and is feasible at the level of primary medical care through history taking, observation and basic neurological examination. The scale demonstrates high psychometric properties and provides risk stratification, enabling individualized monitoring and early intervention strategies. This approach marks a transition to proactive diagnostic models in neurology. It has significant value for screening programs among middle-aged and older individuals with subclinical neurobehavioral complaints. Early detection using PMS assessment allows timely application of neuroprotective and preventive interventions, potentially altering the course of the disease before irreversible neuronal loss.
- Open Access
- 30 June 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (2) , 125-134
Febrile respiratory infections in children: assessment of clinical severity and cerebral vulnerability using the NGCS-RS scale
Acute respiratory infections in children are accompanied by systemic inflammatory, metabolic, and microcirculatory disturbances that may affect the developing brain even without focal neurological symptoms. During critical neurodevelopmental stages, brain function depends on stable oxygenation, perfusion, and energy metabolism, increasing the vulnerability of the neuro-glio-capillary system to combined inflammatory and hypoxic stress. The aim of this study was to substantiate a systemic model of cerebral stability, identify threshold markers of its alteration, and develop the Neuro-Glio-Capillary System Risk Score (NGCS-RS) for early detection of cerebral vulnerability. A retrospective-prospective study included 1,243 children aged 1 month to 18 years. Clinical and laboratory parameters were analyzed throughout the infection course. Inclusion criteria were confirmed viral or bacterial respiratory infections; children with chronic neurological, endocrine, or metabolic disorders were excluded. Participants were divided into viral infection, bacterial infection, and healthy control groups. Statistical validation involved correlation analysis and prognostic modeling. A critical threshold of alteration was identified: C-reactive protein ≥8 mg/L, body temperature ≥39°C, and oxygen saturation ≤90%. Risk scores differed significantly between groups, with the highest values in bacterial infections. Receiver operating characteristic analysis showed excellent accuracy (AUC 0.87). A cutoff of 10 points yielded 85.3% sensitivity and 83.7% specificity. Respiratory infections may be associated with threshold-dependent potential cerebral instability via neuro-glio-capillary dysregulation. The reference standard for validation comprised independent clinical outcomes not included in NGCS-RS scoring: ICU admission, hospital stay >7 days, and/or objective neurological complications. The revised AUC was 0.87 (95% CI: 0.82-0.92), with sensitivity 85.3% and specificity 83.7%, reflecting robust but clinically realistic discriminative performance. The proposed scale may be used for preliminary risk stratification of children at elevated risk of severe course and potential cerebral vulnerability, requiring intensive monitoring.
- 30 June 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (2) , 125-134
Open AccessFebrile respiratory infections in children: assessment of clinical severity and cerebral vulnerability using the NGCS-RS scale
Acute respiratory infections in children are accompanied by systemic inflammatory, metabolic, and microcirculatory disturbances that may affect the developing brain even without focal neurological symptoms. During critical neurodevelopmental stages, brain function depends on stable oxygenation, perfusion, and energy metabolism, increasing the vulnerability of the neuro-glio-capillary system to combined inflammatory and hypoxic stress. The aim of this study was to substantiate a systemic model of cerebral stability, identify threshold markers of its alteration, and develop the Neuro-Glio-Capillary System Risk Score (NGCS-RS) for early detection of cerebral vulnerability. A retrospective-prospective study included 1,243 children aged 1 month to 18 years. Clinical and laboratory parameters were analyzed throughout the infection course. Inclusion criteria were confirmed viral or bacterial respiratory infections; children with chronic neurological, endocrine, or metabolic disorders were excluded. Participants were divided into viral infection, bacterial infection, and healthy control groups. Statistical validation involved correlation analysis and prognostic modeling. A critical threshold of alteration was identified: C-reactive protein ≥8 mg/L, body temperature ≥39°C, and oxygen saturation ≤90%. Risk scores differed significantly between groups, with the highest values in bacterial infections. Receiver operating characteristic analysis showed excellent accuracy (AUC 0.87). A cutoff of 10 points yielded 85.3% sensitivity and 83.7% specificity. Respiratory infections may be associated with threshold-dependent potential cerebral instability via neuro-glio-capillary dysregulation. The reference standard for validation comprised independent clinical outcomes not included in NGCS-RS scoring: ICU admission, hospital stay >7 days, and/or objective neurological complications. The revised AUC was 0.87 (95% CI: 0.82-0.92), with sensitivity 85.3% and specificity 83.7%, reflecting robust but clinically realistic discriminative performance. The proposed scale may be used for preliminary risk stratification of children at elevated risk of severe course and potential cerebral vulnerability, requiring intensive monitoring.
- Open Access
- 11 June 2026
- Published by Zaporizhzhia State Medical and Pharmaceutical University
- Vol. 28 (3) , 267-273
Advancing botulism diagnostics: integrating molecularly specific in vitro platforms and high-sensitivity analytical technologies as alternatives to the mouse bioassay
Accurate detection of botulinum neurotoxin (BoNT) requires assessing both its proteolytic SNARE-cleaving activity and its ability to inhibit synaptic transmission. While the mouse bioassay remains the traditional diagnostic standard, its prolonged turnaround time, limited reproducibility, and ethical constraints underscore the urgent need for advanced in vitro methodologies. Recent advances in analytical chemistry, stem-cell-derived neuronal platforms, and multi-omics profiling enable the development of sensitive systems that replicate BoNT’s molecular and functional mechanisms with greater precision than conventional in vivo models. Aim. To evaluate current methodologies for the diagnosis and functional analysis of botulinum neurotoxin and, synthesizing these findings, to propose a conceptual algorithmic model for comprehensive neurotoxin detection independent of in vivo methods. Materials and methods. A literature review was conducted utilizing the PubMed, Scopus, and Web of Science databases. Studies detailing molecular, cellular, multi-omics, and computational approaches to BoNT detection were included. The extracted data were synthesized across molecular, cellular, and systems-level domains to construct an integrated diagnostic model. Results. Modern diagnostic strategies increasingly surpass the mouse bioassay in terms of sensitivity, specificity, and mechanistic insight. SNARE-specific proteolytic profiling, notably Endopep-MS, enables precise detection of BoNT serotypes and their functional states by quantifying cleavage kinetics across a diverse array of substrates. Complementary human iPSC-derived neuronal platforms allow for direct functional assessment, revealing electrophysiological suppression, altered calcium signaling, and reporter-confirmed SNARE cleavage within living cells. Multi-omics analyses, including single-cell transcriptomics, epigenomics, and metabolomics, capture early stress signatures, serotype-specific responses, and determinants of neuronal susceptibility. Additional resolution is provided by receptor-binding kinetics and intracellular trafficking studies, which elucidate how serotype-dependent variations dictate overall toxicity. The integration of these molecular, cellular, and systems-level insights establishes the foundation for the ULTIMA-BoNT framework, a unified platform designed for high-precision BoNT detection. Conclusions. The convergence of proteolytic assays, physiologically relevant neuronal models, and multi-omics analytics presents a robust, reproducible, and ethically sustainable alternative to the mouse bioassay. This integrative approach not only provides profound mechanistic insights but also supports the predictive analysis of emerging BoNT variants.
- 11 June 2026
- Published by Zaporizhzhia State Medical and Pharmaceutical University
- Vol. 28 (3) , 267-273
Open AccessAdvancing botulism diagnostics: integrating molecularly specific in vitro platforms and high-sensitivity analytical technologies as alternatives to the mouse bioassay
Accurate detection of botulinum neurotoxin (BoNT) requires assessing both its proteolytic SNARE-cleaving activity and its ability to inhibit synaptic transmission. While the mouse bioassay remains the traditional diagnostic standard, its prolonged turnaround time, limited reproducibility, and ethical constraints underscore the urgent need for advanced in vitro methodologies. Recent advances in analytical chemistry, stem-cell-derived neuronal platforms, and multi-omics profiling enable the development of sensitive systems that replicate BoNT’s molecular and functional mechanisms with greater precision than conventional in vivo models. Aim. To evaluate current methodologies for the diagnosis and functional analysis of botulinum neurotoxin and, synthesizing these findings, to propose a conceptual algorithmic model for comprehensive neurotoxin detection independent of in vivo methods. Materials and methods. A literature review was conducted utilizing the PubMed, Scopus, and Web of Science databases. Studies detailing molecular, cellular, multi-omics, and computational approaches to BoNT detection were included. The extracted data were synthesized across molecular, cellular, and systems-level domains to construct an integrated diagnostic model. Results. Modern diagnostic strategies increasingly surpass the mouse bioassay in terms of sensitivity, specificity, and mechanistic insight. SNARE-specific proteolytic profiling, notably Endopep-MS, enables precise detection of BoNT serotypes and their functional states by quantifying cleavage kinetics across a diverse array of substrates. Complementary human iPSC-derived neuronal platforms allow for direct functional assessment, revealing electrophysiological suppression, altered calcium signaling, and reporter-confirmed SNARE cleavage within living cells. Multi-omics analyses, including single-cell transcriptomics, epigenomics, and metabolomics, capture early stress signatures, serotype-specific responses, and determinants of neuronal susceptibility. Additional resolution is provided by receptor-binding kinetics and intracellular trafficking studies, which elucidate how serotype-dependent variations dictate overall toxicity. The integration of these molecular, cellular, and systems-level insights establishes the foundation for the ULTIMA-BoNT framework, a unified platform designed for high-precision BoNT detection. Conclusions. The convergence of proteolytic assays, physiologically relevant neuronal models, and multi-omics analytics presents a robust, reproducible, and ethically sustainable alternative to the mouse bioassay. This integrative approach not only provides profound mechanistic insights but also supports the predictive analysis of emerging BoNT variants.
- Open Access
- 29 May 2026
- Published by Ternopil State Medical University in International Journal of Medicine and Medical Research
- Vol. 12 (1) , 74-83
Comparative clinical efficacy and procedural efficiency of nebuliser vs valved holding chamber in paediatric obstructive bronchitis
Obstructive bronchitis remains a frequent cause of acute respiratory distress in paediatric care. While bronchodilators remain the standard therapeutic approach, the choice between a nebuliser and a pressurised metered- dose inhaler (pMDI) with a valved holding chamber continues to be a subject of clinical debate, particularly regarding younger children. In this prospective observational study, a cohort of 30 children aged 2-8 years was examined to compare the clinical efficacy and usability of these delivery methods. Group A (n = 16) received salbutamol via a jet nebuliser, while Group B (n = 14) utilised a pMDI with a Vortex-type spacer. Despite comparable baseline characteristics (p > 0.05), Group B demonstrated accelerated clinical stabilisation, higher levels of child cooperation, and a reduction in the total number of required inhalations. Notably, the incidence of repeat medical consultations and hospitalisations was lower in the spacer group (7.1% for each outcome) compared to the nebuliser group (25.0% and 12.5%, respectively). These findings suggest that a pMDI with a spacer is a highly effective primary tool for managing mild-to-moderate episodes in outpatient and home settings. Nebuliser therapy should be reserved for severe clinical presentations or patients with significant hypoxia and coordination difficulties, typically requiring supervised clinical observation. Integrating spacers into primary care protocols can optimise treatment efficiency and alleviate the burden on hospital facilities by providing reliable management of less severe obstructions Received: 26.01.2026 | Revised: 29.04.2025 | Accepted: 26.05.2026
- 29 May 2026
- Published by Ternopil State Medical University in International Journal of Medicine and Medical Research
- Vol. 12 (1) , 74-83
Open AccessComparative clinical efficacy and procedural efficiency of nebuliser vs valved holding chamber in paediatric obstructive bronchitis
Obstructive bronchitis remains a frequent cause of acute respiratory distress in paediatric care. While bronchodilators remain the standard therapeutic approach, the choice between a nebuliser and a pressurised metered- dose inhaler (pMDI) with a valved holding chamber continues to be a subject of clinical debate, particularly regarding younger children. In this prospective observational study, a cohort of 30 children aged 2-8 years was examined to compare the clinical efficacy and usability of these delivery methods. Group A (n = 16) received salbutamol via a jet nebuliser, while Group B (n = 14) utilised a pMDI with a Vortex-type spacer. Despite comparable baseline characteristics (p > 0.05), Group B demonstrated accelerated clinical stabilisation, higher levels of child cooperation, and a reduction in the total number of required inhalations. Notably, the incidence of repeat medical consultations and hospitalisations was lower in the spacer group (7.1% for each outcome) compared to the nebuliser group (25.0% and 12.5%, respectively). These findings suggest that a pMDI with a spacer is a highly effective primary tool for managing mild-to-moderate episodes in outpatient and home settings. Nebuliser therapy should be reserved for severe clinical presentations or patients with significant hypoxia and coordination difficulties, typically requiring supervised clinical observation. Integrating spacers into primary care protocols can optimise treatment efficiency and alleviate the burden on hospital facilities by providing reliable management of less severe obstructions Received: 26.01.2026 | Revised: 29.04.2025 | Accepted: 26.05.2026
- Open Access
- 31 March 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (1) , 97-111
Molecular-neurovascular mechanisms of metal implant hypersensitivity as a cause of osteosynthesis failure and delayed bone union: a clinical case study
Metal hypersensitivity is a rare but clinically significant cause of aseptic inflammation and delayed bone union after osteosynthesis. The release of nickel, cobalt, and chromium ions from metal implants induces a T-lymphocyte–mediated delayed-type immune response, which leads to chronic inflammation, endothelial dysfunction, and suppression of osteogenesis. Differentiation of metal-induced hypersensitivity from infectious complications or mechanical instability remains a challenging diagnostic task in orthopedic practice. The aim of the study was to analyze a clinical case of chronic hypersensitivity to a metal implant after tibial osteosynthesis and to identify clinical and diagnostic features linking immune-mediated inflammation with delayed bone union. A retrospective analysis of a clinical case of a patient after tibial osteosynthesis using metal plates was performed. The clinical course, laboratory inflammatory markers, and serial radiographic examinations were evaluated to exclude infection and mechanical fixation failure. The postoperative course was characterized by persistent edema, hyperemia, recurrent seropurulent exudation, and chronic pain in the absence of laboratory signs of bacterial infection. Radiography revealed a lack of progression in bone callus formation despite stable implant fixation. Eight months after surgery, removal of the metal construct led to rapid regression of inflammation, reduction of pain syndrome, and restoration of radiological signs of bone union. Chronic hypersensitivity to metal implants is an underestimated cause of aseptic inflammation and delayed fracture healing. Persistent local inflammatory manifestations without signs of infection, combined with the absence of radiological progression of bone union, should prompt evaluation of a metal-induced immune reaction. Timely implant removal contributes to the restoration of osteogenic balance and bone consolidation.
- 31 March 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (1) , 97-111
Open AccessMolecular-neurovascular mechanisms of metal implant hypersensitivity as a cause of osteosynthesis failure and delayed bone union: a clinical case study
Metal hypersensitivity is a rare but clinically significant cause of aseptic inflammation and delayed bone union after osteosynthesis. The release of nickel, cobalt, and chromium ions from metal implants induces a T-lymphocyte–mediated delayed-type immune response, which leads to chronic inflammation, endothelial dysfunction, and suppression of osteogenesis. Differentiation of metal-induced hypersensitivity from infectious complications or mechanical instability remains a challenging diagnostic task in orthopedic practice. The aim of the study was to analyze a clinical case of chronic hypersensitivity to a metal implant after tibial osteosynthesis and to identify clinical and diagnostic features linking immune-mediated inflammation with delayed bone union. A retrospective analysis of a clinical case of a patient after tibial osteosynthesis using metal plates was performed. The clinical course, laboratory inflammatory markers, and serial radiographic examinations were evaluated to exclude infection and mechanical fixation failure. The postoperative course was characterized by persistent edema, hyperemia, recurrent seropurulent exudation, and chronic pain in the absence of laboratory signs of bacterial infection. Radiography revealed a lack of progression in bone callus formation despite stable implant fixation. Eight months after surgery, removal of the metal construct led to rapid regression of inflammation, reduction of pain syndrome, and restoration of radiological signs of bone union. Chronic hypersensitivity to metal implants is an underestimated cause of aseptic inflammation and delayed fracture healing. Persistent local inflammatory manifestations without signs of infection, combined with the absence of radiological progression of bone union, should prompt evaluation of a metal-induced immune reaction. Timely implant removal contributes to the restoration of osteogenic balance and bone consolidation.
- Open Access
- 23 February 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (1) , 79-89
Treatment of wounds in children in outpatient settings without complete sterility: tactical decisions and safe algorithms
Objective. To determine the characteristics and effectiveness of methods for treating wounds in children in outpatient settings without complete sterility based on an analysis of current literature and our own clinical observations, and to develop safe and practical algorithms for wound treatment in primary pediatric practice. Materials and methods. A systematic review of the literature (using the PubMed, Scopus, and Google Scholar scientific databases) for the last 10 years (40 relevant sources) was combined with clinical observations of 31 children aged 4–18 years who received treatment for accidental wounds in January–June 2025 at a pediatric outpatient department. Most of the injuries were superficial, resulting from domestic accidents or play. Care included washing the wound with sterile saline solution, indirect application of antiseptic (povidone-iodine), and the use of silicone-coated dressings. The frequency of infectious complications, healing time, the need for additional interventions, and the satisfaction of parents/guardians with the treatment results were evaluated. Results. Wound irrigation with saline solution proved to be safe and effective in all children. Povidone-iodine applied through a compress minimized irritation and maintained antimicrobial activity. The use of perforated silicone-coated dressings reduced pain and tissue trauma during dressing changes. No infectious complications were observed in 96.8% of patients. Individualized dressing change frequency (once every 1–2 days for superficial wounds, daily for deeper injuries) optimized the healing process and ensured comfort. Conclusions. The proposed algorithm, which consisted of washing the wound with saline solution under pressure, indirect application of antiseptic, use of silicone dressings, and flexible dressing intervals, demonstrated high safety and efficacy and was acceptable in conditions of partial sterility. Standardization of the approach will improve the quality of outpatient care for children's wounds, reduce the number of complications, and promote its practical implementation in resource-limited settings.
- 23 February 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (1) , 79-89
Open AccessTreatment of wounds in children in outpatient settings without complete sterility: tactical decisions and safe algorithms
Objective. To determine the characteristics and effectiveness of methods for treating wounds in children in outpatient settings without complete sterility based on an analysis of current literature and our own clinical observations, and to develop safe and practical algorithms for wound treatment in primary pediatric practice. Materials and methods. A systematic review of the literature (using the PubMed, Scopus, and Google Scholar scientific databases) for the last 10 years (40 relevant sources) was combined with clinical observations of 31 children aged 4–18 years who received treatment for accidental wounds in January–June 2025 at a pediatric outpatient department. Most of the injuries were superficial, resulting from domestic accidents or play. Care included washing the wound with sterile saline solution, indirect application of antiseptic (povidone-iodine), and the use of silicone-coated dressings. The frequency of infectious complications, healing time, the need for additional interventions, and the satisfaction of parents/guardians with the treatment results were evaluated. Results. Wound irrigation with saline solution proved to be safe and effective in all children. Povidone-iodine applied through a compress minimized irritation and maintained antimicrobial activity. The use of perforated silicone-coated dressings reduced pain and tissue trauma during dressing changes. No infectious complications were observed in 96.8% of patients. Individualized dressing change frequency (once every 1–2 days for superficial wounds, daily for deeper injuries) optimized the healing process and ensured comfort. Conclusions. The proposed algorithm, which consisted of washing the wound with saline solution under pressure, indirect application of antiseptic, use of silicone dressings, and flexible dressing intervals, demonstrated high safety and efficacy and was acceptable in conditions of partial sterility. Standardization of the approach will improve the quality of outpatient care for children's wounds, reduce the number of complications, and promote its practical implementation in resource-limited settings.